Animal models for COVID-19: advances, gaps and perspectives

C Fan, Y Wu, X Rui, Y Yang, C Ling, S Liu… - Signal transduction and …, 2022 - nature.com
Abstract COVID-19, caused by SARS-CoV-2, is the most consequential pandemic of this
century. Since the outbreak in late 2019, animal models have been playing crucial roles in …

Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19

D Cozzi, E Cavigli, C Moroni, O Smorchkova… - Japanese journal of …, 2021 - Springer
Thoracic imaging is fundamental in the diagnostic route of Coronavirus disease 2019
(COVID-19) especially in patients admitted to hospitals. In particular, chest computed …

Comparison of chest CT severity scoring systems for COVID-19

AH Elmokadem, AM Mounir, ZA Ramadan… - European …, 2022 - Springer
Purpose To compare the diagnostic performance and inter-observer agreement of five
different CT chest severity scoring systems for COVID-19 to find the most precise one with …

A rolling circle-amplified G-quadruplex/hemin DNAzyme for chemiluminescence immunoassay of the SARS-CoV-2 protein

R Zhang, J Wu, H Ao, J Fu, B Qiao, Q Wu… - Analytical …, 2021 - ACS Publications
Sensitive detection of the SARS-CoV-2 protein remains a great research interest in clinical
screening and diagnosis owing to the coronavirus epidemic. Here, an ultrasensitive …

Commercial AI solutions in detecting COVID-19 pneumonia in chest CT: not yet ready for clinical implementation?

F Jungmann, L Müller, F Hahn, M Weustenfeld… - European …, 2022 - Springer
Objectives In response to the COVID-19 pandemic, many researchers have developed
artificial intelligence (AI) tools to differentiate COVID-19 pneumonia from other conditions in …

Relationship of the pulmonary disease severity scoring with thromboembolic complications in COVID-19

AH Elmokadem, D Bayoumi, A El-Morsy, A Ehab… - Emergency …, 2022 - Springer
Purpose To correlate thromboembolic (TE) complications secondary to COVID-19 with the
extent of the pulmonary parenchymal disease using CT severity scores and other …

Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi …

N Shi, C Huang, Q Zhang, C Shi, F Liu, F Song… - BMC pulmonary …, 2021 - Springer
Background To explore the long-term trajectories considering pneumonia volumes and
lymphocyte counts with individual data in COVID-19. Methods A cohort of 257 convalescent …

[HTML][HTML] Outcome of percutaneous drainage for septic complications coexisted with COVID-19

MA Deif, AM Mounir, SA Abo-Hedibah… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND The resulting tissue hypoxia and increased inflammation secondary to
severe coronavirus disease 2019 (COVID-19) combined with viral load, and other baseline …

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity

M Jaberi-Douraki, E Meyer, J Riviere, NIM Gedara… - Scientific reports, 2021 - nature.com
Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive
medications with outcomes in patients with hypertension is not fully described. However …

[HTML][HTML] COVID-19 Pneumonia Presenting with Multiple Nodules Mimicking Metastases: An Atypical Case

S Babaoglu, N Poyraz, O Sahin - Journal of the Belgian Society of …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is an outbreak causing pneumonia due to
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and computed tomography …